JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
-
-
-
-
-
-
Rocket Pharmaceuticals (RCKT) shares soar on alignment with FDA on trial; Stifel positive
-
-
-
-
-
-
-
Rocket Pharmaceuticals Expands Cardiac Gene Therapy Portfolio with Addition of RP-A601 for PKP2-ACM and Announces Positive Updated Phase 1 Data for RP-A501 in Danon Disease
-
-
-
-
-
-
-
JPMorgan Positive on Rocket Pharmaceuticals (RCKT), 'we see current share levels as an attractive entry point to capture longer-term pipeline potential'
-
-
-
-
-
-
-
Rocket Pharmaceuticals (RCKT) PT Lowered to $69 at JPMorgan, Following Earnings
-
-
-
-
-
-
-
Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
-
-
-
-
-
276,561 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

